These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
606 related items for PubMed ID: 31244320
1. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer. Hetta HF, Zahran AM, El-Mahdy RI, Nabil EE, Esmaeel HM, Elkady OA, Elkady A, Mohareb DA, Mahmoud Mostafa M, John J. Asian Pac J Cancer Prev; 2019 Jun 01; 20(6):1927-1933. PubMed ID: 31244320 [Abstract] [Full Text] [Related]
2. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. J Thorac Oncol; 2011 Mar 01; 6(3):482-8. PubMed ID: 21258252 [Abstract] [Full Text] [Related]
8. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q. Tumour Biol; 2016 Jun 01; 37(6):7777-84. PubMed ID: 26695145 [Abstract] [Full Text] [Related]
10. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer. Su K, Zhang T, Wang Y, Hao G. World J Surg Oncol; 2016 Aug 24; 14(1):224. PubMed ID: 27733164 [Abstract] [Full Text] [Related]
11. Potential circulating miRNA signature for early detection of NSCLC. Arab A, Karimipoor M, Irani S, Kiani A, Zeinali S, Tafsiri E, Sheikhy K. Cancer Genet; 2017 Oct 24; 216-217():150-158. PubMed ID: 29025589 [Abstract] [Full Text] [Related]
12. Circulating miRNA panels as a novel non-invasive diagnostic, prognostic, and potential predictive biomarkers in non-small cell lung cancer (NSCLC). Abdipourbozorgbaghi M, Vancura A, Radpour R, Haefliger S. Br J Cancer; 2024 Nov 24; 131(8):1350-1362. PubMed ID: 39215192 [Abstract] [Full Text] [Related]
13. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer. Guo W, Zhang Y, Zhang Y, Shi Y, Xi J, Fan H, Xu S. Int J Mol Med; 2015 Dec 24; 36(6):1720-6. PubMed ID: 26497897 [Abstract] [Full Text] [Related]
14. Circulating Plasma miRNAs as Potential Biomarkers of Non-Small Cell Lung Cancer Obtained by High-Throughput Real-Time PCR Profiling. Niu Y, Su M, Wu Y, Fu L, Kang K, Li Q, Li L, Hui G, Li F, Gou D. Cancer Epidemiol Biomarkers Prev; 2019 Feb 24; 28(2):327-336. PubMed ID: 30377207 [Abstract] [Full Text] [Related]
15. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, Xiang Y, Wu N, Wu L, Bai L, Li Y. Oncotarget; 2017 Feb 21; 8(8):13048-13058. PubMed ID: 28055956 [Abstract] [Full Text] [Related]
19. Increased Plasma miRNA-30a as a Biomarker for Non-Small Cell Lung Cancer. Sun L, Chen Y, Su Q, Tang X, Liang Y, Che G, Luo F. Med Sci Monit; 2016 Feb 26; 22():647-55. PubMed ID: 26918265 [Abstract] [Full Text] [Related]
20. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer. Chakra M, Pujol JL, Lamy PJ, Bozonnat MC, Quantin X, Jacot W, Daurès JP. J Thorac Oncol; 2008 Oct 26; 3(10):1119-26. PubMed ID: 18827607 [Abstract] [Full Text] [Related] Page: [Next] [New Search]